Genetic Manipulation Sample Clauses

The Genetic Manipulation clause defines the rules and restrictions regarding the alteration or modification of genetic material within the scope of the agreement. Typically, this clause outlines whether genetic engineering, gene editing, or similar biotechnological interventions are permitted, and may specify the types of organisms or materials covered, such as plants, animals, or microorganisms. Its core function is to ensure compliance with ethical standards, legal regulations, and safety protocols, thereby managing risks associated with genetic technologies and clarifying the parties' responsibilities.
Genetic Manipulation. If a Project involves the use of gene technology (as defined in the Gene Technology Act 2000), then before the proposed research commences, the Administering Organisation must ensure that the research has been approved in writing by the relevant Biosafety and/or Ethics Committees (or equivalent) of the Administering Organisation. The Administering Organisation must retain all certificates relating to the above and will provide evidence to the ARC if required to do so. The Administering Organisation must be accredited with the Office of the Gene Technology Regulator.
View SourceView Similar (6)
Genetic Manipulation. All work involving recombinant nucleic acids must conform to the requirements set out in the Gene Technology Act 2000 (Cth) as amended from time to time. If a Project involves the preparation and/or use of recombinant nucleic acids constructed in vitro from sources that do not ordinarily recombine genetic information, the Administering Institution must obtain approval in writing from the Administering Institution’s Biosafety Committee. If a Project involves or concerns the use of recombinant DNA techniques on animals or humans then, before the proposed research commences, the Administering Institution must ensure that the research has been approved by the relevant Ethics or Biosafety Committee of the Administering Institution. The Administering Institution must retain all certificates of approval relating to the Project and will provide such evidence to the Commonwealth if required to do so.
View SourceView Similar (5)
Genetic Manipulation. If a Project involves the preparation and/or use of recombinant nucleic acids constructed in vitro from sources that do not ordinarily recombine genetic information, approval in writing by the Institution’s Biosafety Committee (or equivalent) or the Office of the Gene Technology Regulator (OGTR) must be obtained.
View Source

Related to Genetic Manipulation

  • Market Manipulation Until the termination of this Agreement, the Company will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation in violation of the Act, Exchange Act or the rules and regulations thereunder of the price of any security of the Company to facilitate the sale or resale of the Shares or otherwise violate any provision of Regulation M under the Exchange Act.

  • Stabilization and Manipulation Neither the Adviser, the Administrator nor any of their respective partners, officers, affiliates or controlling persons has taken, directly or indirectly, any action designed, under the 1934 Act, to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale of the Securities in violation of any law, statute, regulation or rule applicable to the Adviser, the Administrator or any of their respective partners, officers, affiliates or controlling persons.

  • No Manipulation Counterparty is not entering into the Transaction to create actual or apparent trading activity in the Shares (or any security convertible into or exchangeable for the Shares) or to raise or depress or otherwise manipulate the price of the Shares (or any security convertible into or exchangeable for the Shares) or otherwise in violation of the Exchange Act.

  • No Stabilization or Manipulation The Company will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.

  • No Market Stabilization or Manipulation The Company has not taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.